Provenge® (sipuleucel-T)
for Prostate Cancer

Provenge (sipuleucel-T) is an immunotherapy used to treat advanced prostate cancer in men. It contains a protein that stimulates the immune system to target cancer cells. The treatment involves mixing the protein with immune cells from the patient's own blood, which are then re-injected into the body. This is known as autologous immunotherapy, designed to help the immune system respond against cancer.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Prostate Cancer